Austin, United States, Aug. 10, 2026 (GLOBE NEWSWIRE) -- The Analgesics Market Size was valued at USD 52.56 Billion in 2025 and is projected to reach USD 88.85 Billion by 2035, growing at a CAGR of 5.39% during 2026–2035, according to a new report by SNS Insider.
Analgesics Market Growth is driven by rising prevalence of chronic pain conditions, increasing geriatric population across the globe and increase in number of surgeries performed. The need for analgesics remains strong in the care of musculoskeletal pain, neuropathic pain, and postoperative pain among other conditions. Pharma companies can discover new business opportunities with increased focus on non-opioid drugs, advancements in drug delivery, rapid growth of healthcare spending and expanded access to digital healthcare.
Download the Analgesics Market Sample Report: https://www.snsinsider.com/sample-request/1290
Analgesics Market Growth Driven by Rising Chronic Pain and Non-Opioid Therapy Demand
The growing number of cases of chronic pain is a key growth factor for the Analgesics Market globally. Chronic pain impacts a substantial number of adults around the world and has been linked to musculoskeletal problems, nerve disorders, and aging-related degenerative ailments. The need for better pain management is hence driving the use of prescribed and over-the-counter pain medicines. In addition, the risks involved with opioid addiction and strict regulations are fostering research and use of alternative treatments that do not lead to addiction. Pharmaceutical firms are focusing on specific pain targets, antibody treatments, sodium channel inhibitors, non-opioid receptors, and personalized pain treatment.
Analgesics Market Regional Analysis
North America held the top position among regions in the Analgesics Market globally in 2025 with a market share of 38.7%. The growth can be attributed to factors such as heavy expenditure on health care, developed pain management systems, large population of elderly people, high levels of innovation within the pharmaceutical industry, and well-developed distribution channels.
The U.S. Analgesics Market was valued at USD 18.45 billion in 2025 and is projected to reach USD 30.86 billion by 2035, growing at a CAGR of 5.28% during 2026–2035. Growth in the U.S. market is supported by the high prevalence of chronic pain conditions, advanced healthcare infrastructure, a large geriatric population, and significant investment in pain management research and development.
The Asia-Pacific region is expected to display the highest growth rate, with a CAGR of around 6.8% between 2026 and 2035. Growth drivers for the region include expanding access to healthcare, increasing burden of chronic diseases, increased spending on healthcare, aging population, increased diagnostics, growth in OTC market, and increased production of pharmaceuticals in the region.
The Europe Analgesics Market is estimated to be USD 14.72 Billion in 2025 and is projected to reach USD 23.90 Billion by 2035, growing at a CAGR of 4.97% during 2026–2035. Europe is still an essential market due to universal healthcare coverage, distribution of pharmaceuticals, regulatory environment, and awareness about pain management. The aging population and government efforts towards promoting the right usage of analgesics are sustaining the demand.
Segmentation Analysis
By Drug Type
The Non-opioids category held the leading market share of 52.8% in the Analgesics Market in 2025 due to the common application of NSAIDs, acetaminophen, and COX-2 inhibitors in treating mild to moderate pain. The Compound Medication category will witness the highest CAGR of 6.8%, attributed to the growing need for customized formulation, precise dosing, alternate methods of drug delivery, and synergistic drug treatments.
By Route of Administration
The largest market share was held by the Oral segment at 61.3% in 2025. This segment enjoyed its dominance as a result of factors such as ease of use, well-defined prescribing practices, wide availability of products, flexible dosage, and high patient adherence. The Transdermal formulation segment is forecasted to experience the highest growth at a rate of 7.2% CAGR.
By Distribution Channel
The largest market share for Retail Pharmacies was accounted for at 48.7% in 2025 due to wide networks, instant availability, pharmacist consultation, and existing partnerships between pharmacies and healthcare facilities. The fastest growing market will be that of Online Pharmacies, which will grow at a CAGR of 9.4% during the forecast period due to rising healthcare digitization, integration of telemedicine, home deliveries, refill options, and access to analgesic medicines.
By Application
The Musculoskeletal application segment held the highest market share of 34.2% in 2025, which can be attributed to the rising incidences of osteoarthritis, rheumatoid arthritis, back pain, sports injuries, age-related ailments, and sedentary lifestyle. The Neuropathic application segment is anticipated to witness a remarkable growth rate of 7.1% during the forecast period owing to the rising need for specific treatments of diabetic neuropathy, post-herpetic neuralgia, fibromyalgia, and chemotherapy-induced peripheral neuropathy.
Explore the Complete Analgesics Market Report: https://www.snsinsider.com/reports/analgesics-market-1290
Leading Market Players Listed in this Report are:
- Johnson & Johnson
- Pfizer Inc.
- GSK (GlaxoSmithKline)
- Bayer AG
- Novartis AG
- Sanofi
- Reckitt Benckiser
- Sun Pharmaceutical
- Teva Pharmaceutical
- Endo International
- Viatris
- Dr. Reddy's Laboratories
- AstraZeneca
- Eli Lilly and Company
- AbbVie Inc.
- Merck & Co.
- Bristol Myers Squibb
- Takeda Pharmaceutical
- Perrigo Company
- Hikma Pharmaceuticals
Recent Developments:
- 2025: Johnson & Johnson Consumer Health launched Tylenol Rapid Release Gels with 25% faster absorption technology, strengthening its presence in the fast-acting OTC analgesics segment.
- 2024: Pfizer received FDA approval for a novel neuropathic pain indication extension for Lyrica, expanding its addressable patient population in key markets.
Exclusive Sections of the Report (The USPs):
- ANALGESICS DEMAND AND PAIN MANAGEMENT TRENDS ANALYSIS – helps you evaluate analgesic demand across chronic pain, musculoskeletal, neuropathic, postoperative, and other major pain applications.
- NON-OPIOID AND NON-ADDICTIVE THERAPY INSIGHTS – helps you assess the transition toward safer analgesic alternatives, targeted pain pathways, and emerging therapeutic approaches.
- DRUG DELIVERY AND FORMULATION TECHNOLOGY ANALYSIS – helps you understand oral, transdermal, extended-release, compound medication, and advanced delivery trends influencing patient compliance and treatment outcomes.
- DIGITAL HEALTH AND PRESCRIPTION MONITORING TRENDS – helps you evaluate the role of telemedicine, mobile health applications, AI-powered prescription monitoring, medication adherence systems, and digital pain-management platforms.
- ANALGESICS DISTRIBUTION AND MARKET ACCESS ANALYSIS – helps you assess retail pharmacy, online pharmacy, prescription, OTC, and evolving digital distribution channels shaping global market access.
- REGIONAL MARKET AND COMPETITIVE LANDSCAPE ANALYSIS – helps you assess regional demand patterns, pharmaceutical innovation, regulatory developments, healthcare infrastructure, and competitive positioning shaping the global Analgesics Market.
Buy the Analgesics Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/1290
Analgesics Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 52.56 Billion |
| Market Size by 2035 | USD 88.85 Billion |
| CAGR | CAGR of 5.39 % From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Related Market Reports
Ibuprofen API Market Size 2026
Paracetamol IV Market Growth 2026
Non-opioid Pain Patches Market Trends 2026
Pain Management Market Outlook 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
